New Dermal Filler for Chin Correction and Augmentation

A Randomized, Evaluator-blinded, Parallel Group, no Treatment Controlled, Multi-center Study to Evaluate Effectiveness and Safety of GP0109 for Augmentation and Correction of Retrusion in the Chin Region

Randomized, evaluator-blinded, no treatment controlled multicenter study to evaluate safety and effectiveness of GP0109 for augmentation and correction or retrusion in the chin region in Canada

Inclusion Criteria:

• subject willing to comply with the requirements of the study
• subject intent to receive treatment for augmentation and correction of retrusion in the chin region
• subject with mild or moderate (grade 1 or 2) on the GCRS

Exclusion Criteria:

• subjects presenting with know allergy to HA (hyaluronic acid) filler or amide local anesthetics
• subjects with any previous facial surgery below the nasal line or previous HA filler or collagen below the nasal line within 12 months
• subjects in any other interventional clinical study within 30 days before baseline